Ozempic is an injectable prescription medicine used in adults for improving blood sugar control in type 2 diabetes with diet and exercise. It also reduces the risk of major cardiovascular events like heart attack and stroke in adults with type 2 diabetes and established cardiovascular disease. Additionally, it can reduce the risk of kidney function decline and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.
Ozempic (semaglutide)
Semaglutide, the active ingredient in Ozempic, is a GLP-1 receptor agonist that mimics the natural GLP-1 hormone released after eating. This helps regulate blood sugar by stimulating insulin release, slowing stomach emptying, and reducing sugar production by the liver. This can also lead to weight loss by promoting fullness and reducing appetite